Antibody-Dependent Enhancement of Ebola Virus Infection
- 1 July 2003
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 77 (13) , 7539-7544
- https://doi.org/10.1128/jvi.77.13.7539-7544.2003
Abstract
Most strains of Ebola virus cause a rapidly fatal hemorrhagic disease in humans, yet there are still no biologic explanations that adequately account for the extreme virulence of these emerging pathogens. Here we show that Ebola Zaire virus infection in humans induces antibodies that enhance viral infectivity. Plasma or serum from convalescing patients enhanced the infection of primate kidney cells by the Zaire virus, and this enhancement was mediated by antibodies to the viral glycoprotein and by complement component C1q. Our results suggest a novel mechanism of antibody-dependent enhancement of Ebola virus infection, one that would account for the dire outcome of Ebola outbreaks in human populations.Keywords
This publication has 33 references indexed in Scilit:
- Identification of Protective Epitopes on Ebola Virus Glycoprotein at the Single Amino Acid Level by Using Recombinant Vesicular Stomatitis VirusesJournal of Virology, 2003
- Ebola Virus VP40-Induced Particle Formation and Association with the Lipid BilayerJournal of Virology, 2001
- Infectivity-Enhancing Antibodies to Ebola Virus GlycoproteinJournal of Virology, 2001
- Clinical Virology of Ebola Hemorrhagic Fever (EHF): Virus, Virus Antigen, and IgG and IgM Antibody Findings among EHF Patients in Kikwit, Democratic Republic of the Congo, 1995The Journal of Infectious Diseases, 1999
- C1q—how many functions? How many receptors?Trends in Cell Biology, 1998
- Enhancing antibodies in HIV infectionParasitology, 1997
- Complement Activation by HIV-1–Infected CellsJAIDS Journal of Acquired Immune Deficiency Syndromes, 1997
- Infection enhancement of influenza A NWS virus in primary murine macrophages by anti‐hemagglutinin monoclonal antibodyJournal of Medical Virology, 1992
- ANTIBODY-DEPENDENT ENHANCEMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTIONThe Lancet, 1988
- Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibodyThe Journal of Experimental Medicine, 1977